Chemomab Therapeutics Ltd. (NASDAQ:CMMB) Q1 2023 Earnings Call Transcript
Operator: Greetings, and welcome to Chemomab Therapeutics First Quarter 2023 Earnings Call and Corporate Update. At this time, all participants are in a listen-only-mode.
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Citadel Investment Group Ken Griffin | 103,781 | $171,239 | 0% | |
| 2. | ADAR1 Capital Management Daniel Schneeberger | 80,000 | $132,000 | 0.01% | |
| 3. | Ikarian Capital Neil Shahrestani | 51,793 | $85,458 | -3% | 0.01% |
| 4. | Sphera Global Healthcare Fund Doron Breen And Mori Arkin | 0 | $0 | 0% | |
| 5. | Stonepine Capital Timothy P. Lynch | 0 | $0 | 0% |
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.25 | 250 | $812.50 | 2,000 | 2022-03-16 | Filing | |
| $3.30 | 250 | $825.00 | 1,750 | 2022-03-16 | Filing | |
| $2.76 | 33 | $91.08 | 1,433 | 2022-05-24 | Filing | |
| $2.89 | 400 | $1,156.00 | 1,400 | 2022-05-24 | Filing | |
| $3.19 | 2,000 | $6,380.00 | 12,409 | 2022-05-18 | Filing |
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $4.51 | 70,524 | $318,063.24 | 2,241,274 | 2023-01-03 | Filing | |
| $3.34 | 266,376 | $889,695.84 | 2,311,798 | 2023-01-03 | Filing | |
| $5.03 | 6,100 | $30,663.48 | 251,147 | 2023-01-03 | Filing | |
| $5.03 | 7,700 | $38,706.36 | 317,075 | 2023-01-03 | Filing | |
| $2.00 | 2,409 | $4,818.00 | 10,000 | 2022-11-16 | Filing |
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 51,710 | $85,322 | 0% | |
| 2. | 19,013 | $31,371 | 0% | |
| 3. | 17,856 | $29,462 | 0% | |
| 4. | 15,598 | $25,737 | 0% | |
| 5. | 8,125 | $13,406 | 0% |